KLRK1 and neoplasm: DNA hypomethylation augments NK cell-mediated lysis by increasing NKG2D-ligand expression that allows recognition of tumor AML cells by NKG2D receptor (encoded by Killer Cell Lectin Like Receptor K1, KLRK1) on NK cells [57].